AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity
AbCellera Biologics (NASDAQ:ABCL) has seen its stock price jump by 64 percent week-on-week, making it the top-performing mid-cap stock in the US market last week, thanks to strong clinical trial results...








